Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy
- PMID: 16847584
- DOI: 10.1007/s00192-006-0148-0
Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy
Abstract
Intervention for stress urinary incontinence (SUI) is generally focused on minimizing urinary leakage. However, the overall impact of SUI therapy on patients' quality of life is, arguably, more important than leakage outcomes. We performed a literature search to investigate the effect of urethral injection therapy on quality of life. Significant quality-of-life improvements have been observed with a number of injectable agents, while there is a distinct lack of correlation between subjective and objective outcomes. Two studies comparing urethral injection therapy with surgical intervention found superior objective efficacy with surgery, but no significant differences in quality-of-life improvements. Personal goals of patients undergoing urethral injection are yet to be explored, but there may be willingness to trade a lower success rate in favor of a more minor treatment procedure. In conclusion, quality-of-life improvements after urethral injection appear significant and comparable to those obtained with surgery. Further study of patients' own perceptions, pre- and posttreatment, would be valuable.
Similar articles
-
Stress incontinence injection therapy: what is best for our patients?Eur Urol. 2005 Oct;48(4):552-65. doi: 10.1016/j.eururo.2005.06.012. Eur Urol. 2005. PMID: 16118034 Review.
-
An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence.Eur Urol. 2005 Sep;48(3):488-94. doi: 10.1016/j.eururo.2005.05.007. Eur Urol. 2005. PMID: 15967568 Clinical Trial.
-
[Urethral Macroplastique injection as a treatment for female stress incontinence].Ugeskr Laeger. 2004 Aug 30;166(36):3100-2. Ugeskr Laeger. 2004. PMID: 15387310 Danish. No abstract available.
-
Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer.Int Urogynecol J Pelvic Floor Dysfunct. 2003 Nov;14(5):335-8; discussion 338. doi: 10.1007/s00192-003-1075-y. Epub 2003 Sep 13. Int Urogynecol J Pelvic Floor Dysfunct. 2003. PMID: 14618311
-
Bulking agents: an analysis of 500 cases and review of the literature.Int Urogynecol J. 2013 Feb;24(2):241-7. doi: 10.1007/s00192-012-1834-8. Epub 2012 Jun 16. Int Urogynecol J. 2013. PMID: 22707004 Review.
Cited by
-
Urethral bulking agents: techniques and outcomes.Curr Urol Rep. 2009 Sep;10(5):396-400. doi: 10.1007/s11934-009-0062-3. Curr Urol Rep. 2009. PMID: 19709488 Review.
-
Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures.Int Urogynecol J. 2010 Dec;21(12):1479-83. doi: 10.1007/s00192-010-1224-z. Epub 2010 Jul 20. Int Urogynecol J. 2010. PMID: 20645075
-
Combined trans- and periurethral injections of bulking agents for the treatment of intrinsic sphincter deficiency.Int Urogynecol J Pelvic Floor Dysfunct. 2008 May;19(5):643-7. doi: 10.1007/s00192-007-0493-7. Epub 2007 Oct 27. Int Urogynecol J Pelvic Floor Dysfunct. 2008. PMID: 17965815
-
Goal achievement as a patient-generated outcome measure for stress urinary incontinence.Health Expect. 2009 Sep;12(3):288-300. doi: 10.1111/j.1369-7625.2009.00536.x. Health Expect. 2009. PMID: 19754692 Free PMC article.
-
Quality of life after periurethral injection with polyacrylamide hydrogel for stress urinary incontinence.Int Urogynecol J. 2011 Mar;22(3):353-6. doi: 10.1007/s00192-010-1296-9. Epub 2010 Oct 9. Int Urogynecol J. 2011. PMID: 20936255
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical